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Introduction
There is increasing evidence of the important roles played by inositol phosphates in cell biology. While the importance of inositol 1,4,5-trisphosphate as a regulator of intracellular free calcium has been understood for over 20 years, the functions of many of the other inositol phosphates remains less well defined. It is not unreasonable to believe that some of the 60+ inositol phosphates found in eukaryotes are intermediates. Nevertheless, there are an increasing number of inositol phosphates being identified having varied and diverse functions. In addition to calcium signalling, they have been implicated in nuclear mRNA export (York et al., 1999) , chromatin remodelling (Shen et al., 2003; Steger et al., 2003) , DNA repair (Byrum et al., 2004; Hanakahi et al., 2000) , membrane trafficking (Saiardi et al., 2002; Ye et al., 1995) and control of cell proliferation (Orchiston et al., 2004) .
The least studied members of all inositol phosphates are the diphosphoinositol polyphosphates (DIPs). These are phosphorylation products of the most abundant inositol phosphates found in cells, inositol 1,3,4,5,6-pentakisphosphate (InsP 5 ) and inositol hexakisphosphate (InsP 6 ) (Safrany et al., 1999) . Until recently InsP 6 was believed to be the end point in the inositol phosphate kinase cascade. Three human InsP 6 kinases has been identified, producing diphosphoinositol pentakisphosphate (PP-InsP 5 ) (Saiardi et al., 1999; Schell et al., 1999) , a Saccharomyces cerevisiae homologue (KCS1) has also been characterised (Saiardi et al., 2000) . InsP 6 kinases can also phosphorylate InsP 5 , producing diphosphoinositol tetrakisphosphate (PP-InsP 4 ). PP-Ins P 5 can be further phosphorylated by a kinase that is yet to be cloned (Huang et al., 1998) . The structure of the product, bisdiphosphoinositol tetrakisphosphate ([PP] 2 -InsP 4 ), remains to be determined in mammalian systems. Despite their low levels, these DIPs are the most rapidly turned over inositol phosphates in unstimulated cells.
It has previously been shown that PP-InsP 5 can be regulated by the SERCA pump inhibitor, thapsigargin (Glennon and Shears, 1993) . The phosphatases involved in hydrolysis of [PP] 2 -InsP 4 and PP-InsP 5 , termed diphosphoinositol polyphosphate phosphohydrolases are sensitive to fluoride Shears et al., 1995) . As such it was not a surprise to observe that incubating cells with low levels (<mM) fluoride increased levels of PP-InsP 5 and
[PP] 2 -InsP 4 . Higher levels caused a paradoxical decrease in [PP] 2 -InsP 4 levels which was found to be mediated by cyclic nucleotide monophosphates (cNMPs) via an unidentified mechanism .
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The function of these DIPs remains a target for research. It is clear that they play a role in protein trafficking (Saiardi et al., 2000) . In vitro experiments show that PP-InsP 5 and [PP] 2 -InsP 4 can inhibit formation of clathrin triskelia (Ye et al., 1995) . Yeast strains in which the KCS1 gene has been removed show clear trafficking defects (Saiardi et al., 2002) . The major interest is determining which of the DIPs plays a role in vivo.
In this paper, I present, for the first time, new experimental protocols which alter levels of DIPs. Together with previously published data, these treatments will help determine the roles of the DIPs. To this end, I have determined that hyperosmotic stress, caused by treating the Syrian hamster vas deferens smooth muscle cell line DDT 1 MF-2 with sorbitol or sucrose, a treatment that is known to inhibit protein trafficking, also raises [PP] 2 -InsP 4 levels. These results identify a possible mechanism through which hyperosmotic stress acts, and that [PP] 2 -InsP 4 is a regulator of protein trafficking in vivo. These data clearly show that these inositol phosphates are rapidly turned over, and that their pools can be selectively regulated. The protocols developed can be used to determine further the roles played by these inositol phosphates in physiology.
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This article has not been copyedited and formatted. The final version may differ from this version. Park, NC) were maintained in Dulbecco's modified Eagle's medium (DMEM) with 'high-glucose' (i.e. 25 mM), supplemented with 2 mM glutamine and 5% foetal calf serum at 37°C in 5% CO 2 /95% humidified air. Cells were harvested and plated at a density of ~200 000 cells/well (16 mm diameter, 24-well muliplates) in the DMEM-based culture medium described above, supplemented with 50 µCi/ml Experiments were quenched by rapid aspiration of the Krebs-like (or DMEM) media, followed by addition of 250 µl of ice-cold 0.6 M perchloric acid and neutralized by the addition of 70 µl of 1 M K 2 CO 3 containing 5 mM Na 2 EDTA. After being kept at 4°C for 30 min, the perchlorate precipitate was removed by centrifugation (10 000 g, 2 min). The supernatants were finally diluted with 3 volumes of 1 mM Na 2 EDTA. Samples were stored at -20°C prior to being loaded onto a 4.6×125 mm Partisphere 5 µm SAX HPLC column. Inositol phosphates were eluted at 1 ml/min by the following gradient generated by mixing buffer A (1 mM Na 2 EDTA) and buffer B [buffer A plus 1.3 M (NH 4 ) 2 HPO 4 , pH 3.85 with H 3 PO 4 ; total [Pi] = 2.6 M] as follows: 0-5 min, 0% B; 5-10 min, 0-50% B; 10-60 min, 50-100% B; 60-70 min, 100% B.
Fractions were collected at 1-min intervals, mixed with 4.2 vols of Flo-Scint IV scintillant, and radioactivity was determined using liquid scintillation spectrometry. EC 50 values were derived using Prism (GraphPad, San Diego, CA). Inositol lipids were extracted from the perchloric acid pellet, prepared and analysed as previously described (Batty and Downes, 1994) . Peaks were ascribed by co-elution of standards in parallel runs.
ATP levels were determined using a luciferase-based assay kit (Merck Biosciences, Nottingham UK), following the manufacturer's recommended protocol. Samples were either prepared as described above 7 This article has not been copyedited and formatted. The final version may differ from this version. I have also identified that genistein, a broad-range protein tyrosine kinase inhibitor (Akiyama et al., 1987 EC 50 of 28µM. This is in close agreement with the published IC 50 for pp60 v-src of 26µM (Akiyama et al., 1987) .
These effects were not mimicked by a similar protein kinase inhibitor, herbimycin A (10µM, data not shown), therefore excluding the role of a pp60 v-src -like kinase in regulating PP-InsP 5 phosphorylation. Dephostatin (100µM) and mpV(pic) (100µM), protein tyrosine phosphatase inhibitors, like the broad inhibitor, okadaic acid (1µM) were without effect. mpV(pic) did, however greatly raise levels of InsP 4 , by over 15-fold over control levels (data not shown). This is the first observation of mpV(pic) raising inositol phosphate levels, presumably by activating phospholipase C. The mechanism by which genistein lowered [PP] 2 -InsP 4 is unclear. The roles of MEK, LCK, p70S6 kinase, phosphoinositide 3-kinase and smooth muscle myosin light chain kinase were excluded by the lack of effect of SB203580 (10µM), PD98059 (1mM), rapamycin (100nM) and wortmanin (100nM) (data not shown).
That InsP 3 3-kinases are regulated by calmodulin-dependent kinase (Dewaste et al., 2000) , suggested that the gateway to all the HIPs could be regulated by calmodulin kinase inhibitors. Low levels of W-7, a calmodulin inhibitor, were without effect. Higher levels (>10µM), however, caused a marked and rapid decline of HIPs and DIPs, InsP 5 to [PP] 2 -InsP 4 , although the ratios between each of these remained constant, identifying that there was a specific block at the level of InsP 5 production ( Figure 4 ). Similar data were obtained with chlorpromazine (Byrum et al., 2004) , whereas KN-93 (500µM) and K-252a (50µM), calmodulin kinase inhibitors were without effect. As W-7 has been proposed as being cytotoxic (Jan et al., 2000) , its effects were more systematically assessed. Cells treated with W-7 or chlorpromazine (up to 1mM) for 1 hour excluded trypan blue (>97% exclusion), even following a 24 hour recovery period in DMEM. At this highest dose, a morphological change occurred. Cells lost their usual stellate shapes are became rounded. This is consistent with a significant decrease in cellular phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P 2 ) levels, which is accompanied by an increase in phosphatidylinositol 4-phosphate (PtdIns(4)P) (Figure 5a ). Adenosine 5'-triphosphate (ATP) levels were also determined. These, like inositol phosphate levels, were seriously compromised at higher doses of both W-7 and chlorpromazine ( Figure 5b ).
Measurement of extracellular ATP and inositol phosphate levels indicated that much of that lost was recoverable from outside the cells. This indicates that, despite being impermeant to trypan blue, the cell membranes allowed the passage of ATP and inositol phosphates.
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Potassium depletion of cells has also been shown to inhibit protein trafficking, and so potassium regulation of DIPs has also been investigated. Amiloride (1mM), ouabain (100µM), Cs + (10mM), Ba + (1mM) and tetraethylammonium (20mM) were all found to have no effect. Equally oxidative stress, afforded by treatment of cells with hydrogen peroxide (100µM), was without effect. Arachidonic acid (30µM) also did not alter levels of DIPs. No effect on levels was observed treating cells with histamine (acting on H1 receptors (Cowlen et al., 1990) ), lipopolysaccharide (10µM), ZD7288 (1mM), cycloheximide (100µg/ml), pertussis toxin (50ng/ml) or dexamethazone (1nM). Also tested without effect were PP2 (10µM), and its control PP3 (10µM) and platelet-derived growth factor (50ng/ml).
Using these data, along with those previously published, we can now address the roles of DIPs and HIPs in a cellular Figure 6 ). Interferons α, β and γ were unable to affect levels of inositol phosphates, despite interferon β having been shown to upregulate InsP 6 kinase (Morrison et al., 2001) .
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This article has not been copyedited and formatted. The final version may differ from this version. In attempting to understand the mechanism by which cNMPs, I have tested a number of treatments that implicate cNMPs as acting through novel pathways. cNMPs cause activation of the glucocorticoid receptor, these effects may be partly PKA-independent (Eickelberg et al., 1999) . The ability of dexamethasone to alter [PP] 2 -InsP 4 was tested.
The lack of effects suggests that GR activation by cNMPs is not upstream of the effects on DIPs. A report that cNMPs can also regulate Na + channels (Niisato et al., 1999) (Niisato et al., 1999) . Because cNMPs are known to activate Ih currents (Bosmith et al., 1993) , the effects of ZD7288, an effective and selective blocker of Ih channels was tested. ZD7288 had no reproducible effect alone, nor did it alter the ability of cNMPs to lower [PP] 2 -InsP 4 .
The potent effects of genistein in lowering [PP] 2 -InsP 4 levels, and subsequently PP-InsP 5 levels raises further concerns regarding the specificity of this drug as a protein kinase inhibitor. One could suggest that the recorded effects of genistein now need reanalysing, to determine whether some of its effects can be attributed to its regulation of [PP] 2 -InsP 4 . The mechanism of action of genistein and herbimycin differ greatly. Herbimycin acts via binding to protein sulfhydryl groups, genistein competes with ATP at the active site (Simonson and Herman, 1993) . These data suggest that the active site of PP-InsP 5 kinase resembles a protein tyrosine kinase ATP-binding pocket.
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The ability of sorbitol to raise [PP] 2 -InsP 4 levels suggests that the effects of hyperosmotic stress on protein trafficking (Oka et al., 1989) may be mediated by these effects, as [PP] 2 -InsP 4 has been previously shown to inhibit clathrin triskelion formation (Ye et al., 1995) . Much discussion has taken place as to whether inositol phosphates or inositol lipids are the key ligands for proteins involved in the inhibition of clathrin triskelia (see (Gaidarov et al., 1996; Hao et al., 1997) ), yet from this and earlier (Jones et al., 1999 ) studies, it is apparent that levels of 3-phosphorylated inositides is decreased, and only levels of [PP] 2 -InsP 4 are increased. In contrast, K + depletion and cytosolic acidification, other treatments known to inhibit protein trafficking (Hansen et al., 1993) , did not mimic sorbitol in its ability to raise [PP] 2 -InsP 4 . This suggests that these reagents have their effects by different mechanisms; it will be interesting to determine how these other treatments alter trafficking. It is noted that in S.
cerevisiae a reduction in levels of DIPs leads to inhibited trafficking, and it is proposed that inositol phosphatebinding proteins could be regulated in a fashion analogous to heterotrimeric G-proteins (Saiardi et al., 2002) . A recent paper by Sajan et al. (Sajan et al., 2002) showed that sorbitol activated atypical PKC and GLUT4 glucose transporter translocation, and that these events were mediated by extracellular signal-regulated kinase and We have recently used W-7 and chlorpromazine to study the effects of depleting HIPs on Ku70 function (Byrum et al., 2004) . Under conditions whereby InsP 5 to [PP] 2 -InsP 4 are reduced, Ku70 mobility is perturbed. These data suggest that some of these inositol phosphates represent physiological regulators of DNA-dependent protein kinase, whereby Ku70 requires inositol phosphates to relocate to areas of DNA damage (Byrum et al., 2004) . W-7 and chlorpromazine also affected levels of inositol lipids and depleted ATP. These observations mirror those made previously in human platelets (Strunecka et al., 1987; Tharmapathy et al., 2000) . PtdIns(4,5)P 2 is required for cytoskeletal integrity (Niebuhr et al., 2002) , its depletion leading to a change in cellular morphology. Significant loss of ATP and inositol phosphates to the media would suggest that these cells are permeable to these small molecules (Holmsen and Rygh, 1990) , and could explain how exogenous InsP 6 could effect Ku70 mobilization in W-7-treated cells (Byrum et al., 2004) . The effects observed suggest that the cationic amphiphilic nature of these compounds
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This article has not been copyedited and formatted. The final version may differ from this version. MOL 2667 allows shielding of the negative charge of ATP and inositol phosphates (among other components) thus allowing them to pass through the membrane down their concentration gradients. The effects on adenine nucleotides could be mimicked by the cationic detergent cetyl-trimethylammonium bromide, whereas in contrast, the anionic detergent dioctyl sulfosuccinate was without effect (Tharmapathy et al., 2000) . The complex nature of the effects of W-7 and chlorpromazine may bring into question their usefulness in further studies of HIP and DIP function. It is clear that they have a number of other effects above that of calmodulin antagonists, although the ability of extracellular inositol phosphates to rescue a response can act as a good control.
I have also recently shown that InsP 5 levels can be selectively lowered by overexpressing PTEN M-CBR3. Such treatment of U87-MG cells decreased their proliferative rate (Orchiston et al., 2004) . While no manipulation that selectively regulates InsP 6 levels has yet been described, the overexpression of cytosolic multiple inositol polyphosphate phosphatase, achieved by removal of the C-terminal ER recycling signal (SDEL), has been shown previously to lower InsP 5 by 60%, and InsP 6 levels by 40%. This treatment, too, was found to cause a decrease in the rate of cell proliferation (Chi et al., 2000) . It would be expected that such decreases in the levels of these DIP precursors would also lead to a decrease in the DIPs themselves, although this was not addressed in the above papers. A combination of these two approaches in parallel may yield insight into the roles of InsP 6 in mammalian cells.
These results, complemented by earlier studies, identify means by which DIPs can be regulated. analyzed by HPLC as described in Materials and Methods. The identity of each peak was ascertained by reference to previous data using this HPLC system (Glennon and Shears, 1993; Shears et al., 1995) , and by using standards of This article has not been copyedited and formatted. The final version may differ from this version. 
